Cell therapy biotech Tolerance Bio has unveiled with $17.2 million and a mission of targeting immune diseases by stretching ...

Tolerance Bio has launched with an oversubscribed $17.2 million seed round and a goal to develop therapies for ...

In an audacious bid to rewrite the narrative of cancer treatment, scientists are converging on an ingenious approach: ...

A bushy, dwarf, evergreen shrub up to 30cm tall and 40cm wide; with small, linear to ovate, aromatic, dark grey-green leaves, and terminal spikes of small, whorled, white or pink flowers in early ...

Glioblastoma is the most common and most aggressive primary brain tumor, with an average survival after diagnosis of less than two years, and against which current treatments remain ineffective.

Drugs that are effective against brain tumors are difficult to find, as many cancer drugs often can't cross the blood-brain barrier to reach the brain. This limits the choice of possible ...

As Dr. Jarrod Dudakov puts it, “The thymus is a really special organ. On one hand, it’s incredibly sensitive to acute insults like infection, stress, or the radiation and chemotherapies we use to ...

Case presentation: This is a case of primary adenocarcinoma with intestinal differentiation and focal mucin production in the thymus. Thymic cyst was associated with this tumor. Intestinal ...

Migratory DCs carry peripheral self antigens into the thymus and thereby may extend the scope of intrathymically presented self antigens. Other biological implications of the heterogeneity of ...

A mediastinal tumor is a growth that occurs in the space inside the chest, near organs such as the heart and lungs. Some of these tumors may cause symptoms, but some may not. When mediastinal ...

The tumor was classified as a thymoma, but 2 features were thought to be unusual: the large number of "plasmacytoid" cells; and the cellular pattern presented in Figure 1 f. (The slides were ...